Healthtech Startups

Proactive For Her provides in-person and virtual women's healthcare across areas including menstrual and sexual health, cancer screening, fertility, egg freezing, PCOS, pelvic health, mental health, and postpartum care. It serves women through clinics staffed by trauma-informed doctors offering non-judgemental care.

2 investors

Probo Medical is a global provider of diagnostic imaging equipment and services that sells, rents, and repairs ultrasound systems, CT, MRI, X-ray, and other medical imaging devices to hospitals, imaging centers, veterinary clinics, and specialty medical practices. The company serves medical professionals across cardiology, women's health, pain management, and veterinary medicine with refurbished and new diagnostic imaging systems at competitive prices.

2 investors

Proem Behavioral Health provides a digital behavioral health assessment platform and exclusively licensed clinical instruments (including the M.I.N.I.) used to screen, diagnose, monitor and measure outcomes for mental health and substance use disorders. It serves healthcare providers—primary care, pediatrics, behavioral health, FQHCs and SUD clinics—as well as clinical researchers selecting and tracking trial participants.

2 investors

Profility provides an AI-powered platform that automates the creation and management of prior authorizations for patients in skilled nursing and home health settings. The platform integrates with electronic medical records and analyzes managed care contracts to help case managers and healthcare providers streamline authorization workflows.

2 investors

Profundus develops an ophthalmic retinal camera that uses Multi Conjugate Adaptive Optics (MCAO) with multiple deformable mirrors to capture high-resolution, wide-field images of the retina. The device resolves retinal features down to a few microns and offers higher resolution and a larger field of view than conventional fundus cameras and single-conjugate adaptive optics systems.</parameter> <parameter name="founders">[]

2 investors

Prolocor is developing diagnostic tests related to atherosclerotic cardiovascular disease and thrombotic risk, including platelet FcγRIIa-based assessment of risk in cancer patients. Its work is oriented toward clinical and medical diagnostics in the United States.

2 investors

Prolucent provides a workforce management platform and services for health systems to manage permanent and flexible clinical talent, covering recruitment marketing, internal resource pools, external agency optimization, and workforce analytics. Its technology integrates with existing WFM, HRIS, and ERP systems to reduce contract labor costs and improve staffing efficiency.

2 investors

Promentis Pharmaceuticals is a privately-held biopharmaceutical company developing oral compounds targeting the System xc- glutamate pathway to treat neuropsychiatric disorders. Its lead indication is trichotillomania, and its work extends to other obsessive-compulsive, addictive, and CNS conditions.

2 investors

ProMIS Neurosciences is a clinical-stage biotechnology company developing antibody therapeutics that target toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's, ALS, and Parkinson's. The company operates in the biotechnology and neurology therapeutics space.

2 investors

Prompt Health is a cloud-based, AI-powered electronic medical record and practice management platform designed exclusively for outpatient rehabilitation therapy clinics including physical therapy, occupational therapy, speech therapy, pediatric therapy, and chiropractic practices. The platform integrates clinical documentation, scheduling, billing, patient engagement, compliance, and analytics in a single system.

2 investors

PromptWell provides an AI-native engagement platform designed for healthcare organizations and health plans to personalize member communications and guide them toward appropriate care services. The platform combines automated outreach, interactive workflows, and behavioral analytics to increase member engagement, reduce costs, and improve health outcomes.

2 investors

Reve is an AI revenue cycle management platform for hospitals and healthcare providers that validates claims before submission, audits payments, and manages denials to reduce denied and underpaid insurance claims. Built by former health insurance system designers, it covers the claim lifecycle from pre-surgery authorization checks through post-payment audit.

2 investors

ProofPilot is a sponsor-configured clinical trial platform covering the study lifecycle from enrollment forecasting through patient engagement, with tools for recruitment, site training, and participant retention. It serves clinical operations teams at biotechs and large pharma companies, offering a white-labeled, end-to-end alternative to piecing together multiple clinical trial vendors.

2 investors

Prosoria is an over-the-counter consumer healthcare company that develops pharmaceutical-grade products for chronic health conditions using scientifically-tested formulations. The company focuses on creating safer and more effective alternatives to traditional treatments, serving customers seeking improved quality of life through better health solutions.

2 investors

Prosper Health is a telehealth platform providing psychological assessment and therapy services, with a focus on supporting neurodivergent and autistic adults. The platform connects clients with licensed psychologists, clinical social workers, and licensed therapists across multiple states who specialize in neurodiversity-affirming care.

2 investors

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

2 investors

Protalix is a biopharmaceutical company that develops and manufactures innovative pharmaceutical products, including treatments for orphan and rare diseases. The company leverages its proprietary technology platform and extensive expertise in drug development, regulatory affairs, and pharmaceutical manufacturing.

2 investors

Protego Bio is a biotech company developing first-in-class therapies for protein misfolding diseases, including its lead candidate PROT-001 for AL amyloidosis, based on research into pharmacological chaperones. Its work targets patients affected by protein misfolding disorders.

2 investors

Protego Health provides AI-powered software that prevents insurance claim denials and automates appeals for healthcare organizations. The platform integrates into existing EHR systems to flag denial risks at the point of order, clinical note, and claim creation, and generates payer-specific appeals when denials occur.

2 investors

Proteina develops single-molecule protein-protein interaction (PPI) detection technology (SPID) that generates real-time, high-resolution data to support therapeutic drug development. The company applies PPI analysis toward precision medicine.

2 investors

ProTgen is a clinical-stage biotechnology company developing targeted Notch activators that generate progenitor T cells to restore thymic function and adaptive immune competence. Its work spans ex vivo cell therapy (ProT-096) and in vivo biologic programs (RGT-096).

2 investors

Prothea Technologies develops fluorescence imaging and optical sensing technologies for respiratory medicine and oncology applications. The company creates medical devices and diagnostic platforms focused on advancing clinical validation and regulatory approval for respiratory and cancer care.

2 investors

Proveca is a paediatric-focused pharmaceutical company that develops, licenses, and distributes medicines designed specifically for children, including conducting clinical trials for safety, efficacy, and age-appropriate formulations. It serves healthcare providers, carers, and paediatric patients, with a global ambition across the US, Canada, Europe, and Japan.

2 investors

Sanofi is a pharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients globally. The company operates in over 100 countries with a focus on breakthrough science and healthcare innovation.

2 investors